Last edition
News about "autoimmune "
Eli Lilly to Acquire Merida Biosciences in Deal Valued at Up to USD 2.875 Billion
Eli Lilly will acquire Merida Biosciences for up to $2.875 billion to advance precision therapies targeting disease-causing autoantibodies.
Autoimmune | 01/09/2026 | By News Bureau | 118
FDA Grants FTD to RemeGen Telitacicept for Treatment of pSS
RemeGen Co. Ltd. Has received Fast Track Designation (FTD) by the US Food and Drug Administration (FDA) for its innovative BLyS/APRIL dual-target fusion protein drug.
Autoimmune | 03/04/2024 | By Aishwarya | 667
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy